The closing price of Zevra Therapeutics Inc (NASDAQ: ZVRA) was $10.81 for the day, down -3.74% from the previous closing price of $11.23. In other words, the price has decreased by -$3.74 from its previous closing price. On the day, 1.09 million shares were traded. ZVRA stock price reached its highest trading level at $11.54 during the session, while it also had its lowest trading level at $10.69.
Ratios:
Our analysis of ZVRA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.93 and its Current Ratio is at 3.02. In the meantime, Its Debt-to-Equity ratio is 1.51 whereas as Long-Term Debt/Eq ratio is at 1.49.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on July 02, 2025, initiated with a Buy rating and assigned the stock a target price of $26.
On October 07, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $20.Guggenheim initiated its Buy rating on October 07, 2024, with a $20 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 26 ’25 when Thompson Rahsaan sold 24,000 shares for $9.21 per share. The transaction valued at 221,004 led to the insider holds 42,666 shares of the business.
RAHSAAN THOMPSON bought 24,000 shares of ZVRA for $223,920 on Jun 26 ’25. On Mar 28 ’25, another insider, Watton Corey Michael, who serves as the Director of the company, bought 300 shares for $7.84 each. As a result, the insider paid 2,352 and bolstered with 1,800 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZVRA now has a Market Capitalization of 591086528 and an Enterprise Value of 590292928. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.56 while its Price-to-Book (P/B) ratio in mrq is 14.41. Its current Enterprise Value per Revenue stands at 14.544 whereas that against EBITDA is -9.025.
Stock Price History:
The Beta on a monthly basis for ZVRA is 1.88, which has changed by 0.9654546 over the last 52 weeks, in comparison to a change of 0.17535925 over the same period for the S&P500. Over the past 52 weeks, ZVRA has reached a high of $13.16, while it has fallen to a 52-week low of $5.45. The 50-Day Moving Average of the stock is 9.32%, while the 200-Day Moving Average is calculated to be 26.54%.
Shares Statistics:
ZVRA traded an average of 847.78K shares per day over the past three months and 1169220 shares per day over the past ten days. A total of 54.68M shares are outstanding, with a floating share count of 54.03M. Insiders hold about 1.18% of the company’s shares, while institutions hold 65.31% stake in the company. Shares short for ZVRA as of 1752537600 were 4895563 with a Short Ratio of 5.77, compared to 1749772800 on 4711373. Therefore, it implies a Short% of Shares Outstanding of 4895563 and a Short% of Float of 9.0100005.
